PolyNovo Limited (ASX: PNV) has received its first orders of BTM from PMI for use in Germany, Austria and Switzerland. The first orders for NovoSorb BTM were shipped to hospitals in preparation for the first surgery.
- The company announced its first surgery in Europe using BTM in Germany;
- At the launch of BTM numerous surgeons made clear their intention to use the product soon;
- The company got its EU approval in mid-December .
At AEDT 01:15PM, the stock was trading at $2.790 per share, up by 9.412% from its previous close.